Patient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest group

Simple item page
dc.contributor.authorThomas, Megan
dc.contributor.authorFraenkel, Liana
dc.contributor.authorBoonen, Annelies
dc.contributor.authorBansback, Nick
dc.contributor.authorBuchbinder, Rachelle
dc.contributor.authorMarshall, Deborah
dc.contributor.authorProulx, Laurie
dc.contributor.authorVoshaar, Marieke
dc.contributor.authorRichards, Pamela
dc.contributor.authorRichards, Dawn P
dc.contributor.authorHiligsmann, Mickael
dc.contributor.authorGuillemin, Francis
dc.contributor.authorShea, Beverly
dc.contributor.authorTugwell, Peter
dc.contributor.authorHazlewood, Glen
dc.date.accessioned2022-01-03T21:31:24Z
dc.date.available2022-01-03T21:31:24Z
dc.date.issued2021-05-24
dc.description.abstractObjective. To inform a research plan for future studies by obtaining stakeholder input on the application of preference-based methods to clinical trial design. Methods. We conducted a virtual OMERACT session to encourage stakeholder engagement. We developed materials for the session to facilitate discussion based on identified case examples and feedback sessions. Results. Participants prioritized incorporating patient preferences in all aspects of trial design with an emphasis on outcome selection. Participants highlighted the need for careful consideration around preference heterogeneity and equity factors. Conclusion. Including patient preferences in trial design was considered a priority requiring further exploration to develop comprehensive guidance.en_US
dc.description.grantingagencyCanadian Institutes of Health Research (CIHR)en_US
dc.identifier.citationGlen S Hazlewood, Adalberto Loyola-Sanchez, Vivian Bykerk, Pauline M Hull, Deborah Marshall, Tram Pham, Claire E H Barber, Cheryl Barnabe, Alexandra Sirois, Janet Pope, Orit Schieir, Dawn Richards, Laurie Proulx, Susan J Bartlett, Corrigendum to: Patient and Rheumatologist Perspectives on Tapering DMARDs in Rheumatoid Arthritis: A Qualitative Study, Rheumatology, Volume 60, Issue 11, November 2021, Page 5484, https://doi.org/10.1093/rheumatology/keab482en_US
dc.identifier.doihttp://dx.doi.org/10.1016/j.semarthrit.2021.05.008en_US
dc.identifier.grantnumberFRN 156267en_US
dc.identifier.urihttp://hdl.handle.net/1880/114246
dc.language.isoengen_US
dc.publisherOxford University Press, British Society for Rheumatologyen_US
dc.publisher.departmentMedicineen_US
dc.publisher.facultyCumming School of Medicineen_US
dc.publisher.hasversionacceptedVersionen_US
dc.publisher.institutionUniversity of Calgaryen_US
dc.publisher.policyhttps://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/author_self_archiving_policyen_US
dc.subjectOMERACTen_US
dc.subjectPatient preferencesen_US
dc.subjectPreference-based methodsen_US
dc.subjectRheumatologyen_US
dc.subjectClinical trialsen_US
dc.subjectTrade-offsen_US
dc.titlePatient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest groupen_US
dc.typejournal articleen_US
ucalgary.item.requestcopytrueen_US
ucalgary.scholar.levelFacultyen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Tapering Perspectives RA_accepted manuscript.pdf
Size:
645.54 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.92 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Cumming School of Medicine Research & Publications